SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

ACADIA Pharmaceuticals Inc. ACAD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Analyst Price Target

ACADIA Pharmaceuticals Inc. (ACAD) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 AKRO, ATHA, BPMC, CABA, FBIO, HEPA 等.

ACAD 的市值为 $3.71B, 而同行平均市值为 $3.87B.

同行与相似公司 — ACAD

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

Athira Pharma, Inc.

$6.75 -6.12% $26.62M

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

Cabaletta Bio, Inc.

$3.40 +4.29% $327.3M

Fortress Biotech, Inc.

$2.43 +0.41% $78.25M

Hepion Pharmaceuticals, Inc.

$0.04 -19.58% $448.54K

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Krystal Biotech, Inc.

$268.54 -0.54% $7.85B

Madrigal Pharmaceuticals, Inc.

$518.58 -1.22% $11.9B

PTC Therapeutics, Inc.

$73.57 +0.77% $6.09B

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

Reviva Pharmaceuticals Holdings, Inc.

$0.89 +3.35% $3.02M

其他人也在看

Madrigal Pharmaceuticals, Inc.

Blueprint Medicines Corporation

Krystal Biotech, Inc.

Reata Pharmaceuticals, Inc.

PTC Therapeutics, Inc.

Terns Pharmaceuticals, Inc.

Akero Therapeutics, Inc.

Viking Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言